AMBOSS

by AMBOSS  · Based in Germany → — Cut Through the Noise. Show Up With Confidence.
Family Medicine Hospital Medicine Internal Medicine

Available
Regulatory Status Disclosed

Overview

AMBOSS is an AI-driven adaptive learning platform and comprehensive medical knowledge resource designed to empower medical students, physicians, and educators. It bridges the gap between technology and clinical excellence by providing trusted, evidence-based knowledge and smart solutions. The platform customizes instruction, question banks, and resources based on individual performance, supporting users from preclinical studies through residency and beyond.

It offers a dynamic medical knowledge system linked to Qbanks and AI-powered analytics for exam preparation, as well as a clinical reference tool for fast, evidence-based, and actionable information enhanced by the latest AI technology. AMBOSS also provides educator support tools to create assignments, monitor student progress, and facilitate targeted remediation.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Knowledge Library (1,500+ preclinical and clinical topics)
  • Qbanks (13,900+ questions for various exams)
  • AI Mode Learning (personal AI study copilot)
  • AI Mode Clinical Care (clinical decision support)
  • Differential Diagnosis
  • Management Checklists
  • Clinical Calculators
  • Drug Database
  • One Minute Telegram
  • Anki Add-on
  • Chrome Extension
  • USMLE Score Predictor and personalized analytics
  • High-yield study plans
  • Educator Tools (create assignments, monitor progress)

Use Cases

  • Medical exam preparation (USMLE, COMLEX, Shelf Exams, PANCE/PANRE, EOR, ABIM, ABFM, ABP, ABEM)
  • Clinical decision support at the point of care
  • Adaptive learning for medical students and residents
  • Educator support for teaching and remediation
  • Residency program curriculum integration
  • Staying updated with evidence-based medical knowledge

What Physicians Need to Know

Evidence Base (guidelines, literature scope)
AMBOSS content is developed by a team of over 150 physicians, based on the latest evidence, and undergoes a rigorous 4-step clinician-review process. It prioritizes high-quality systematic reviews, meta-analyses (e.g., Cochrane Reviews), and highly-graded guideline recommendations, drawing from sources like the American Heart Association (AHA) and American College of Cardiology (ACC). The platform features over 1,400 articles covering foundational and clinical sciences, with content continuously updated daily to reflect current research and best medical practice. [5, 9, 11, 12, 14, 1, 6, 23]
Clinical Validation Studies
AMBOSS's AI Mode Clinical Care was ranked #1 in a recent Harvard-Stanford benchmark study. Users have shown improved outcomes, with AMBOSS users scoring 10.4 points higher on Step 2 CK. A resident survey indicated that 95% of residents believe AMBOSS helps them be better doctors. The tool also significantly improves efficiency, with residents finding information in an average of 90 seconds, saving over 20 minutes per shift, and reducing inquiries to seniors by 33%. [3, 12, 20, 26]
Alert Fatigue Management
While AMBOSS is not primarily an alerting system, its design focuses on providing concise, action-driven content and quick, reliable answers to help physicians efficiently find relevant information, thereby indirectly reducing the cognitive load that can contribute to alert fatigue. [4, 9]
Drug Interaction Checking
AMBOSS integrates a comprehensive Drug Database directly from the AHFS (American Hospital Formulary Service) database, a recognized gold standard for drug information. This database is updated monthly and includes essential information such as compatibility tables, drug interaction data, and dosing tables, alongside AMBOSS editorial content. [5, 9, 10, 12, 21, 23, 25]
Differential Diagnosis Support
The platform offers a robust Differential Diagnosis (DDx) tool that provides targeted lists to help physicians quickly arrive at the most probable diagnosis. Users can navigate to the DDx section within articles, filter out unlikely conditions, and access necessary diagnostic studies for possible conditions. [5, 7, 8, 9, 11, 15, 26]
Guideline Update Frequency
AMBOSS content, including clinical articles and the integrated drug database, is diligently updated daily by a team of clinician editors to reflect current clinical guidelines and the most recent evidence. Drug information from the AHFS database is updated monthly. Users can also access an in-platform overview of monthly content additions and updates. [9, 10, 11, 12, 14, 21, 24]
Clinical Workflow Integration
AMBOSS is designed for seamless integration into clinical workflows, offering features like 'Clinic Connect' which can read patient charts, reason with trusted knowledge, and suggest next steps, including writing structured output back into the EHR. It provides mobile apps with offline access, a Chrome extension for pop-up explanations, Anki integrations, interactive clinical management checklists, quick guides, and flowcharts. The platform is designed as an 'all-in-one resource' to minimize switching between tools. [1, 2, 9, 12, 13, 15, 17, 18, 23, 26, 27, 32, 34]
Decision Audit Trail
AMBOSS does not explicitly offer a 'decision audit trail' feature. Its primary function is to provide comprehensive medical knowledge and decision support, rather than to log or track individual clinical decisions made by the user within an EHR system.
Physician Tip

Leverage AMBOSS's 'Clinician Mode' for tailored content and quick access to diagnostic algorithms, management checklists, and the integrated drug database at the point of care. Utilize the mobile app's offline mode for reliable access in areas with poor connectivity. For efficient learning and board preparation, integrate AMBOSS with Anki and use the Chrome extension for quick definitions and article access while browsing. The 'AI Mode Clinical Care' can provide quick, curated answers grounded in the AMBOSS knowledge base, but always review the linked sources for independent clinical judgment. [1, 2, 9, 12, 15, 23, 26, 34]

AMBOSS offers robust integrations to enhance workflow and learning, including a Chrome extension for web-based content access and Anki add-ons for flashcard-based learning. The 'Clinic Connect' initiative aims for deeper integration with EHRs, allowing AMBOSS to analyze patient data and provide context-aware support directly within the clinical chart. While AMBOSS strives for accessibility across third-party integrations, their performance may be outside direct control. [1, 2, 16, 17, 18, 23, 26]

Details

Category Clinical Decision Support & Reference, Medical Education & Training
Pricing Available
  • Monthly, Yearly, or Student Life memberships available
  • All memberships include full access to the AMBOSS library and clinical tools
  • Includes 50 Qbank questions per month by default, with full Qbank access available as an additional one-time purchase
  • AMA medical student and resident members receive an exclusive 10% discount on the Knowledge Library and Qbank add-on
  • The Student Life package offers unlimited access from purchase until the end of the first year of residency
DeploymentWeb-based, Mobile Apps
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Not applicable AI-estimated
Integrations
EHR Not specified
Specialties Family Medicine, Hospital Medicine, Internal Medicine

What the Web Says

AMBOSS is a comprehensive medical learning platform highly regarded by physicians and medical students for its in-depth content, question bank, and integration with clinical practice. It's praised for its user-friendly interface and the ability to link directly to relevant information during study or clinical work. While generally positive, some users find the amount of information overwhelming or the cost a barrier.

Overall: Positive

Strengths

  • Comprehensive and up-to-date medical content
  • High-quality question bank with detailed explanations
  • Integration with clinical practice via 'Attending Mode'
  • User-friendly interface and intuitive navigation
  • Excellent for exam preparation (USMLE, shelf exams)
  • Visual aids and interactive features enhance learning

Limitations

  • Can be overwhelming due to the sheer volume of information
  • Subscription cost can be prohibitive for some students/residents
  • Some users prefer other platforms for specific question styles
  • Mobile app functionality could be improved according to some
  • May contain more detail than necessary for certain quick reviews
  • Occasional minor inaccuracies or outdated information (though rare)

Based on reviews from: Reddit (r/medicalschool, r/step1, r/usmle), G2, Capterra, Physician blogs and forums, Student Doctor Network

Last updated: 2026-07-27

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AMBOSS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

AMBOSS Newsroom / PR Newswire
AMBOSS closes u20ac240M financing round and expands its position as the leading co-pilot for physicians worldwide
AMBOSS secured u20ac240 million in a financing round with new long-term investors KIRKBI, M&G Investments, and Lightrock, alongside existing shareholders, to accelerate international expansion and extend offerings to other healthcare professionals like nurses. The company also converted to a European stock corporation (SE) and plans further investments in technology and strategic acquisitions.
2025-03
AMBOSS Newsroom
AMBOSS Acquires NEJM Knowledge+ from NEJM Group, Setting a New Standard in Medical Education and Clinical Practice
AMBOSS announced its acquisition of NEJM Knowledge+, a learning and assessment tool from NEJM Group, aiming to create a fully integrated platform for board exam preparation and clinical practice. This acquisition is expected to enhance resources for healthcare professionals from medical school through clinical practice.
2024-04
Distill Intelligence
AMBOSS's LiSA performed best in clinical AI study
AMBOSS's AI Mode Clinical Care (LiSA 1.0) achieved the top safety-weighted performance with the fewest severe errors in a Stanford-Harvard clinical AI study, outperforming generalist models due to its curated medical knowledge base. This highlights AMBOSS's commitment to patient safety and responsible AI integration.
2026-07
AMBOSS Newsroom
AMBOSS introduces AI Mode Learning: Your AI Study Copilot
AMBOSS launched AI Mode Learning, an AI study copilot integrated into its platform, designed to provide trusted explanations, targeted practice, and progress tracking for medical learners. This feature aims to help students understand concepts, learn actively, and prepare for exams.
2026-02
AMBOSS Newsroom
Same mission, redesigned navigation: AMBOSS evolves as a medical intelligence platform
AMBOSS unveiled a redesigned navigation, evolving into a medical intelligence platform that seamlessly connects learning, clinical care, and teaching. This update aims to provide a unified and personalized experience for students, healthcare professionals, and educators, adapting to various roles and healthcare systems.
2026-01
AMBOSS Newsroom
AMBOSS MCP: Grounding AI Tools in Trusted Medical Knowledge
AMBOSS introduced its Model Context Protocol (MCP) server, an open-source interface that provides AI agents with real-time access to its physician-verified knowledge base. This initiative aims to ground AI outputs in medical evidence, ensuring accuracy and trustworthiness in clinical environments.
2025-09
AMBOSS Newsroom
AMBOSS Healthcare Integrations: Clinical Reasoning Built Into the Chart
AMBOSS announced healthcare integrations that bring its AI Mode into clinical workflows, allowing it to analyze patient data, reason with trusted knowledge, and suggest next steps directly within the EHR. This aims to close the loop between clinical guidance and action, enhancing decision-making at the point of care.
2025-12
American Medical Association
How AMBOSS helps medical students maximize exam performance
AMBOSS offers a comprehensive study aid for medical students, including a Qbank with over 11,000 questions covering 100% of USMLE exam content, a digital library, and resources for NBME Shelf exams. The platform helps learners strategically approach questions and provides personalized recommendations for efficient study.
2025-10

Videos

Product demos, reviews, and walkthroughs for AMBOSS.

View all on YouTube

Frequently Asked Questions

AMBOSS is designed for rapid access to evidence-based medical information, allowing physicians to quickly look up diagnoses, treatments, and clinical guidelines at the point of care. Its intuitive interface, powerful search functionality, and mobile apps with offline access help streamline finding relevant information during patient encounters or rounds.
AMBOSS content is continuously updated by a team of over 80 physicians and medical experts, ensuring it reflects the latest evidence-based medicine and clinical guidelines. The information undergoes a rigorous '8-eyes principle' review process for accuracy and applicability, with sources from reputable journals and professional societies clearly cited.
While all provide evidence-based clinical information, AMBOSS is often highlighted for its integrated learning features, including question banks and detailed explanations, which can be beneficial for continuous medical education alongside clinical use. Physicians may find its structured knowledge, visual aids, and focus on learnability a distinct advantage compared to the more traditional reference formats of some alternatives.
AMBOSS offers various subscription models, including monthly, yearly, and 'Student Life' memberships, with pricing that can vary based on features and duration. All memberships typically include full access to the AMBOSS Library and clinical tools, with an option to add comprehensive Qbank access.
While comprehensive, AMBOSS, like any single resource, may not always cover every rare condition or highly specialized niche in exhaustive detail. Physicians should view it as a robust primary tool but be prepared to consult highly specialized journals, expert consultations, or institutional guidelines for extremely complex or unique patient cases.
Yes, AMBOSS provides dedicated mobile applications for both iOS and Android devices, allowing physicians to access its extensive content on the go. Crucially, these apps also support offline access for downloaded content, ensuring continuous clinical decision support even without an internet connection.
AMBOSS maintains compliance by having its content developed and continuously updated by a team of physicians who incorporate the latest evidence-based medicine and clinical guidelines. The editorial process includes multiple reviews to ensure accuracy, applicability, and alignment with current best practices from reputable medical organizations.

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-04-27 | First Added: 2026-04-27

Investors who backed AMBOSS

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.